tiprankstipranks
Trending News
More News >
HeraMED Ltd. (AU:HMD)
ASX:HMD
Advertisement

HeraMED Ltd. (HMD) Price & Analysis

Compare
3 Followers

HMD Stock Chart & Stats


HeraMED Ltd. News

HMD FAQ

What was HeraMED Ltd.’s price range in the past 12 months?
HeraMED Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
    What is HeraMED Ltd.’s market cap?
    HeraMED Ltd.’s market cap is €37.48M.
      When is HeraMED Ltd.’s upcoming earnings report date?
      HeraMED Ltd.’s upcoming earnings report date is Mar 04, 2026 which is in 175 days.
        How were HeraMED Ltd.’s earnings last quarter?
        HeraMED Ltd. released its earnings results on Aug 28, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
          Is HeraMED Ltd. overvalued?
          According to Wall Street analysts HeraMED Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does HeraMED Ltd. pay dividends?
            HeraMED Ltd. does not currently pay dividends.
            What is HeraMED Ltd.’s EPS estimate?
            HeraMED Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does HeraMED Ltd. have?
            HeraMED Ltd. has 1,041,052,700 shares outstanding.
              What happened to HeraMED Ltd.’s price movement after its last earnings report?
              HeraMED Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of HeraMED Ltd.?
                Currently, no hedge funds are holding shares in AU:HMD

                HeraMED Ltd. Stock Smart Score

                Company Description

                HeraMED Ltd.

                HeraMED Ltd. (HMD) is a healthcare technology company specializing in innovative maternal and fetal health solutions. The company operates within the digital health sector, offering advanced medical-grade devices and software platforms designed to enhance prenatal care. Its core products include the HeraBEAT, an FDA-approved fetal heart rate monitor, and the HeraCARE platform, which provides comprehensive telehealth services and remote monitoring solutions for expectant mothers and healthcare providers.

                HeraMED Ltd. (HMD) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Uscom Limited
                Atomo Diagnostics Ltd.
                Adherium Ltd.
                InhaleRx Limited
                Control Bionics Ltd.
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis